Clinical relevance of MGMT in the treatment of cancerGERSON, Stanton L.Journal of clinical oncology. 2002, Vol 20, Num 9, pp 2388-2399, issn 0732-183XArticle

Targeted modulation of MGMT : Clinical implicationsLILI LIU; GERSON, Stanton L.Clinical cancer research. 2006, Vol 12, Num 2, pp 328-331, issn 1078-0432, 4 p.Article

RACIAL DIFFERENCE IN COLOR VISION: DO THEY EXISTDWYER WO; STANTON L.1975; AMER. J. OPTOM. PHYSIOL. OPT.; U.S.A.; DA. 1975; VOL. 52; NO 3; PP. 224-229; BIBL. 10REF.Article

Driving change, creating valueSTANTON, L.Info chimie magazine. 1999, Num NOV, pp 23-25, issn 1286-0921, NSConference Paper

CLOSE COLLISION CROSS SECTIONS FOR IONS AND SYMMETRIC TOP MOLECULESHYATT D; STANTON L.1973; J. CHEM. SOC., FARADAY TRANS., 2; G.B.; DA. 1973; VOL. 69; PP. 340-348; BIBL. 12 REF.Serial Issue

Immunotherapy of cancer with genetically modified tumor vaccinesGILBOA, E.Seminars in oncology. 1996, Vol 23, Num 1, pp 101-107, issn 0093-7754Article

Repopulating defect of mismatch repair-deficient hematopoietic stem cellsREESE, Jane S; LILI LIU; GERSON, Stanton L et al.Blood. 2003, Vol 102, Num 5, pp 1626-1633, issn 0006-4971, 8 p.Article

Gene therapyLATTIME, Edmund C; GERSON, Stanton L.Seminars in oncology. 1996, Vol 23, Num 1, pp 1-197, issn 0093-7754Serial Issue

CLINICAL EVALUATION OF ELECTRON RADIOGRAPHY. CURRENT STATUS.WALLNER PE; BRADY LW; STANTON L et al.1976; RADIOLOGY; U.S.A.; DA. 1976; VOL. 120; NO 1; PP. 203-204Article

REMOVAL OF SINGULARITIES IN THE NUMERICAL INTEGRALS FOR AN STO BASIS SET.CARELESS PN; HYATT D; STANTON L et al.1977; INTERNATION. J. QUANTUM CHEM.; U.S.A.; DA. 1977; VOL. 12; NO 3; PP. 569-578; ABS. FR. ALLEM.; BIBL. 9 REF.Article

Zedergol'm's Life of Elder Leonid of Optina : Apophthegm, Person, and the Chronotope of EncounterSTANTON, L. J.Religion and Literature. 1990, Vol 22, Num 1, pp 19-38, issn 0029-4500Article

A BREAST PHANTOM METHOD FOR EVALUATING MAMMOGRAPHY TECHNIQUESTANTON L; VILLAFANA T; DAY JL et al.1978; INVEST. RADIOL.; USA; DA. 1978; VOL. 13; NO 4; PP. 291-297; BIBL. 20 REF.Article

COMPARISON OF ION CHAMBER AND TLD DOSIMETRY IN MAMMOGRAPHYSTANTON L; DAY JL; BRATTELLI SD et al.1981; MED. PHYS. (LANC.); ISSN 0094-2405; USA; DA. 1981; VOL. 8; NO 6; PP. 792-798; BIBL. 13 REF.Article

AUDITORY EVOKED POTENTIALS AND AUDITORY BEHAVIOR FOLLOWING PRENATAL AND PERINATAL ASPHYXIA IN RHESUS MONKEYSMIRSKY AF; ORREN MM; STANTON L et al.1979; DEVELOP. PSYCHOBIOL.; USA; DA. 1979; VOL. 12; NO 4; PP. 369-379; BIBL. 20 REF.Article

CORONARY ARTERY SURGERY IN AUSTRALIA, 1975-1976. A REPORT BY THE NATIONAL HEART FOUNDATION OF AUSTRALIA.READER R; BERNSTEIN L; CLAREBROUGH JK et al.1977; MED. J. AUSTRAL.; AUSTRAL.; DA. 1977; VOL. 1; NO 9; PP. 273-277 (4P.); BIBL. 1 REF.Article

Measurement of anti-cancer agent methoxyamine in plasma by tandem mass spectrometry with on-line sample extractionSHUMING YANG; LIU, Lili; GERSON, Stanton L et al.Journal of chromatography. B. 2003, Vol 795, Num 2, pp 295-307, issn 1570-0232, 13 p.Article

Chemotherapy-induced O⁶-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancerLIU, Lili; SCHWARTZ, Stuart; DAVIS, Brian M et al.Cancer research (Baltimore). 2002, Vol 62, Num 11, pp 3070-3076, issn 0008-5472Article

Genomic targeting and genetic conversion in cancer therapyKMIEC, E. B.Seminars in oncology. 1996, Vol 23, Num 1, pp 188-193, issn 0093-7754Article

Tissue specific promoters in targeting systemically delivered gene therapyHART, I. R.Seminars in oncology. 1996, Vol 23, Num 1, pp 154-158, issn 0093-7754Article

MEASUREMENTS OF DIAGNOSTIC X-RAY BACKSCATTER BY A NOVEL ION CHAMBER METHODSTANTON L; BRATTELLI SD; DAY JL et al.1982; MED. PHYS. (LANC.); ISSN 0094-2405; USA; DA. 1982; VOL. 9; NO 1; PP. 121-130; BIBL. 18 REF.Article

RAPID COMPUTATION OF DIAGNOSTIC X-RAY BREMSSTRAHLUNG SPECTRASTANTON L; DAY JL; LIGHTFOOT DA et al.1979; RADIOLOGY; USA; DA. 1979; VOL. 130; NO 2; PP. 477-484; BIBL. 10 REF.Article

IMAGE CHARACTERISTICS OF LIQUID DEVELOPED ELECTRON RADIOGRAPHS.STANTON L; BRADY LW; WALLNER P et al.1976; RADIOLOGY; U.S.A.; DA. 1976; VOL. 120; NO 2; PP. 421-422; BIBL. 4 REF.Article

Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screenTAVERNA, Pietro; LIU, Lili; HANSON, Amy J et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 6, pp 507-516, issn 0344-5704Article

Novel genetic immunotoxins and intracellular antibodies for cancer therapySI-YI CHEN; MARASCO, W. A.Seminars in oncology. 1996, Vol 23, Num 1, pp 148-153, issn 0093-7754Article

Some results concerning the estimation of beta distribution parameters in PERTFARNUM, N. R; STANTON, L. W.The Journal of the Operational Research Society. 1987, Vol 38, Num 3, pp 287-290, issn 0160-5682Article